Rights and permissions
About this article
Cite this article
Azithromycin cost effective for MAC prophylaxis in HIV-positive patients. Pharmacoecon. Outcomes News 248, 7 (2000). https://doi.org/10.1007/BF03275360
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275360